Literature DB >> 19614718

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.

S C A Chen1, D Marriott, E G Playford, Q Nguyen, D Ellis, W Meyer, T C Sorrell, M Slavin.   

Abstract

The risk factors for and clinical features of bloodstream infection with uncommon Candida spp. (species other than C. albicans, C. glabrata, C. parapsilosis, C. tropicals and C. krusei) are incompletely defined. To identify clinical variables associated with these species that might guide management, 57 cases of candidaemia resulting from uncommon Candida spp. were analysed in comparison with 517 episodes of Candida albicans candidaemia (2001-2004). Infection with uncommon Candida spp. (5.3% of candidaemia cases), as compared with C. albicans candidaemia, was significantly more likely to be outpatient-acquired than inpatient-acquired (15 of 57 vs. 65 of 517 episodes, p 0.01). Prior exposure to fluconazole was uncommon (n=1). Candida dubliniensis was the commonest species (n=22, 39%), followed by Candida guilliermondii (n=11, 19%) and Candida lusitaniae (n=7, 12%).C. dubliniensis candidaemia was independently associated with recent intravenous drug use (p 0.01) and chronic liver disease (p 0.03), and infection with species other than C. dubliniensis was independently associated with age<65 years (p 0.02), male sex (p 0.03) and human immunodeficiency virus infection (p 0.05). Presence of sepsis at diagnosis and crude 30-day mortality rates were similar for C. dubliniensis-related, non-C. dubliniensis-related and C. albicans-related candidaemia. Haematological malignancy was the commonest predisposing factor in C. guilliermondii (n=3, 27%) and C. lusitaniae (n=3, 43%) candidaemia. The 30-day mortality rate of C. lusitaniae candidaemia was higher than the overall death rate for all uncommon Candida spp. (42.9% vs. 25%, p not significant). All isolates were susceptible to amphotericin B, voriconazole, posaconazole, and caspofungin; five strains (9%) had fluconazole MIC values of 16-32 mg/L. Candidaemia due to uncommon Candida spp. is emerging among hospital outpatients; certain clinical variables may assist in recognition of this entity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19614718     DOI: 10.1111/j.1469-0691.2009.02821.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  31 in total

1.  In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.

Authors:  Sharon C-A Chen; Chayanika Biswas; Robyn Bartley; Fred Widmer; Namfon Pantarat; Daniel Obando; Julianne T Djordjevic; David H Ellis; Katrina A Jolliffe; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species.

Authors:  Lindsay G Stevenson; Steven K Drake; Yvonne R Shea; Adrian M Zelazny; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

3.  Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.

Authors:  Brunella Posteraro; Alberto Ruggeri; Elena De Carolis; Riccardo Torelli; Antonietta Vella; Flavio De Maio; Walter Ricciardi; Patrizia Posteraro; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

4.  Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast.

Authors:  Neelam Dhiman; Leslie Hall; Sherri L Wohlfiel; Seanne P Buckwalter; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

5.  Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).

Authors:  Michael A Pfaller; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  J Antibiot (Tokyo)       Date:  2015-04-22       Impact factor: 2.649

6.  Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.

Authors:  M A De Francesco; G Piccinelli; M Gelmi; F Gargiulo; G Ravizzola; G Pinsi; L Peroni; C Bonfanti; A Caruso
Journal:  Mycopathologia       Date:  2017-06-08       Impact factor: 2.574

7.  Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.

Authors:  Xin Hou; Meng Xiao; Sharon C-A Chen; He Wang; Jing-Wei Cheng; Xin-Xin Chen; Zhi-Peng Xu; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2016-08-17       Impact factor: 5.948

8.  Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.

Authors:  M A Pfaller; M Castanheira; D J Diekema; S A Messer; G J Moet; R N Jones
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

Review 9.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

10.  Three clustered cases of candidemia caused by Candida quercitrusa and mycological characteristics of this novel species.

Authors:  Meng Xiao; He Wang; Juan Lu; Sharon C-A Chen; Fanrong Kong; Xiao-Jun Ma; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2014-04-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.